Atlas Trials

Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura

Clinical trial NCT00251277 · WITHDRAWN

Trial details

NCT number
NCT00251277
Sponsor
Weill Medical College of Cornell University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Thrombotic Thrombocytopenic Purpura
Start date
2005-11-01
Primary completion
2009-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.